Ritivel develops AI native regulatory workforce platform for regulatory and medical writing teams at life science companies.
Ritivel has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2026.
Ritivel's investors include Y Combinator.
Ritivel is headquartered in San Francisco, United States.
Ritivel develops AI native regulatory workforce platform for regulatory and medical writing teams at life science companies.
Ritivel is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ritivel — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/ritivel. Accessed August 14, 2026.
VCBacked. (2026). Ritivel — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ritivel
{{cite web |title=Ritivel — Funding & Investors |url=https://www.vcbacked.co/company/ritivel |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated